Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer
Clinical trial NCT01150630 · COMPLETED
Trial details
- NCT number
- NCT01150630
- Sponsor
- IRCCS San Raffaele
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2017-04-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.